| Followers | 54 |
| Posts | 6684 |
| Boards Moderated | 0 |
| Alias Born | 01/11/2017 |
Tuesday, May 18, 2021 9:18:46 AM
Thank you! He’s doing ok…but still a little ways to go.
Putting has been awful…always been my Achilles heel and hope you’re knocking some pins down.
Pin- I don’t disagree that these government agencies aren’t chatting with one another and it’s a symbiotic relationship for sure but to not lay any (IMO it’s should be 99%) of the blame at Naders feet is whistling past the graveyard. I’m just the messenger but one can only do so much. Nader’s track record is abysmal from day one!
Financing- horrible deals with shady companies
BP- won’t work with Cytodyn
Pestell- world-renowned and Nader fires him. Discovery will show what happened either way
Unjust enrichment- stealing shares twice and being sued.
BLA- was slippery with the truth when “mock” data sets were installed then tried blame the RTF on a syringe issue.
CD10- he was advised NOT to do it because it was nearly impossible to prove LL had any substantive value in mild cases. Ergo- people just got better on their own.
I could go on but the point I’m making is that I agree the FDA and other government agencies can put their thumb on the scale when they want. Trust me, I’ve worked with a number of government agencies at many levels: you play or you pay! BUT, Nader gave them every reason to not help. Nobody is going to stick their neck out for an unknown Bio company with a shady CEO. I just don’t believe in coincidences. I don’t believe the FDA or Fauci want people to die, I don’t believe that FDA is doing CYDY harm just to help BP. BP doesn’t care about Cytodyn because they’ve measured leadership and decided Nader would eventually hang himself. When Nader gets fired, and he will get fired, I may jump in. I believe in the science but it’s going to take expertise, precision and expertise. These are traits Nader lacks. He’s a used-car salesman that couldn’t deliver the car.
Time will tell who’s right and who isn’t. Hope you’re still able to profit and Cytodyn shareholders get the leadership they deserve. For those that continue to point the arrow away from Nader are destined for major losses. It’s not much more complex than that.
Putting has been awful…always been my Achilles heel and hope you’re knocking some pins down.
Pin- I don’t disagree that these government agencies aren’t chatting with one another and it’s a symbiotic relationship for sure but to not lay any (IMO it’s should be 99%) of the blame at Naders feet is whistling past the graveyard. I’m just the messenger but one can only do so much. Nader’s track record is abysmal from day one!
Financing- horrible deals with shady companies
BP- won’t work with Cytodyn
Pestell- world-renowned and Nader fires him. Discovery will show what happened either way
Unjust enrichment- stealing shares twice and being sued.
BLA- was slippery with the truth when “mock” data sets were installed then tried blame the RTF on a syringe issue.
CD10- he was advised NOT to do it because it was nearly impossible to prove LL had any substantive value in mild cases. Ergo- people just got better on their own.
I could go on but the point I’m making is that I agree the FDA and other government agencies can put their thumb on the scale when they want. Trust me, I’ve worked with a number of government agencies at many levels: you play or you pay! BUT, Nader gave them every reason to not help. Nobody is going to stick their neck out for an unknown Bio company with a shady CEO. I just don’t believe in coincidences. I don’t believe the FDA or Fauci want people to die, I don’t believe that FDA is doing CYDY harm just to help BP. BP doesn’t care about Cytodyn because they’ve measured leadership and decided Nader would eventually hang himself. When Nader gets fired, and he will get fired, I may jump in. I believe in the science but it’s going to take expertise, precision and expertise. These are traits Nader lacks. He’s a used-car salesman that couldn’t deliver the car.
Time will tell who’s right and who isn’t. Hope you’re still able to profit and Cytodyn shareholders get the leadership they deserve. For those that continue to point the arrow away from Nader are destined for major losses. It’s not much more complex than that.
Recent CYDY News
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 05/21/2026 04:15:12 AM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 05/20/2026 09:08:39 PM
- CytoDyn to Present at the LD Micro Invitational XVI • GlobeNewswire Inc. • 05/15/2026 12:30:00 PM
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • InvestorsHub NewsWire • 05/11/2026 01:00:00 PM
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • GlobeNewswire Inc. • 05/11/2026 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/30/2026 08:32:50 PM
- CytoDyn Announces First Patient Dosed in Expanded Access Program for Leronlimab in Triple-Negative Breast Cancer • GlobeNewswire Inc. • 04/27/2026 12:30:00 PM
- CytoDyn to Host Investor Webcast • GlobeNewswire Inc. • 04/23/2026 12:30:00 PM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 04/22/2026 09:21:50 PM
- CytoDyn Presents New Leronlimab Data in Metastatic Colorectal Cancer at AACR Annual Meeting 2026 • GlobeNewswire Inc. • 04/22/2026 12:30:00 PM
- CytoDyn Completes Enrollment in Phase 2 Metastatic Colorectal Cancer Study • GlobeNewswire Inc. • 04/21/2026 08:10:00 PM
- CytoDyn Presents New Leronlimab Data in Metastatic Triple-Negative Breast Cancer at AACR Annual Meeting 2026 • GlobeNewswire Inc. • 04/20/2026 12:30:00 PM
- CytoDyn to Present at the AACR Annual Meeting 2026 • GlobeNewswire Inc. • 04/14/2026 12:30:00 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 04/08/2026 09:15:18 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 04/08/2026 12:30:28 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 03/25/2026 09:16:10 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 09:24:23 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 09:23:14 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 09:22:42 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 09:21:33 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 09:20:57 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 09:20:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/24/2026 09:15:24 PM
- CytoDyn Presents at AACR Special Conference in Cancer Research: Brain Cancer • GlobeNewswire Inc. • 03/24/2026 12:30:00 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 03/09/2026 09:15:18 PM
